T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity.
Saved in:
| Title: | T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity. |
|---|---|
| Authors: | Schmid D; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Microbiology & Immunobiology, Harvard Medical School, Boston, MA, 02215, USA., Park CG; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Microbiology & Immunobiology, Harvard Medical School, Boston, MA, 02215, USA., Hartl CA; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Subedi N; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Cartwright AN; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Puerto RB; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Zheng Y; Department of Biological Engineering, MIT, Cambridge, MA, 02139, USA.; Koch Institute for Integrative Cancer Research, Cambridge, MA, 02139, USA., Maiarana J; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Freeman GJ; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Wucherpfennig KW; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Irvine DJ; Department of Biological Engineering, MIT, Cambridge, MA, 02139, USA.; Koch Institute for Integrative Cancer Research, Cambridge, MA, 02139, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, 20815, USA., Goldberg MS; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. michael_goldberg1@dfci.harvard.edu.; Department of Microbiology & Immunobiology, Harvard Medical School, Boston, MA, 02215, USA. michael_goldberg1@dfci.harvard.edu. |
| Source: | Nature communications [Nat Commun] 2017 Nov 23; Vol. 8 (1), pp. 1747. Date of Electronic Publication: 2017 Nov 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29170511 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schmid+D%22">Schmid D</searchLink>; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Microbiology & Immunobiology, Harvard Medical School, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Park+CG%22">Park CG</searchLink>; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Microbiology & Immunobiology, Harvard Medical School, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Hartl+CA%22">Hartl CA</searchLink>; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Subedi+N%22">Subedi N</searchLink>; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Cartwright+AN%22">Cartwright AN</searchLink>; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Puerto+RB%22">Puerto RB</searchLink>; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Zheng+Y%22">Zheng Y</searchLink>; Department of Biological Engineering, MIT, Cambridge, MA, 02139, USA.; Koch Institute for Integrative Cancer Research, Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Maiarana+J%22">Maiarana J</searchLink>; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Freeman+GJ%22">Freeman GJ</searchLink>; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Wucherpfennig+KW%22">Wucherpfennig KW</searchLink>; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Irvine+DJ%22">Irvine DJ</searchLink>; Department of Biological Engineering, MIT, Cambridge, MA, 02139, USA.; Koch Institute for Integrative Cancer Research, Cambridge, MA, 02139, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, 20815, USA.<br /><searchLink fieldCode="AU" term="%22Goldberg+MS%22">Goldberg MS</searchLink>; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. michael&#95;goldberg1@dfci.harvard.edu.; Department of Microbiology & Immunobiology, Harvard Medical School, Boston, MA, 02215, USA. michael&#95;goldberg1@dfci.harvard.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2017 Nov 23; Vol. 8 (1), pp. 1747. <i>Date of Electronic Publication: </i>2017 Nov 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29170511 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-017-01830-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1747 Titles: – TitleFull: T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schmid D – PersonEntity: Name: NameFull: Park CG – PersonEntity: Name: NameFull: Hartl CA – PersonEntity: Name: NameFull: Subedi N – PersonEntity: Name: NameFull: Cartwright AN – PersonEntity: Name: NameFull: Puerto RB – PersonEntity: Name: NameFull: Zheng Y – PersonEntity: Name: NameFull: Maiarana J – PersonEntity: Name: NameFull: Freeman GJ – PersonEntity: Name: NameFull: Wucherpfennig KW – PersonEntity: Name: NameFull: Irvine DJ – PersonEntity: Name: NameFull: Goldberg MS IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 11 Text: 2017 Nov 23 Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 8 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |